Annexon (ANNX) Insider Trading & Ownership $2.56 -0.05 (-1.72%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Annexon (NASDAQ:ANNX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.67%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$64.68KNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$224.44K Get ANNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Annexon stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ANNX Insider Buying and Selling by Quarter Annexon Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/30/2025William H CarsonDirectorBuy4,115$2.46$10,122.90 2/18/2025Dean Richard ArtisEVPSell5,515$2.97$16,379.55 2/18/2025Jamie DananbergInsiderSell5,521$2.96$16,342.16 2/18/2025Jennifer LewCFOSell6,912$2.92$20,183.04 2/13/2025Douglas LoveCEOSell5,021$2.95$14,811.95 2/13/2025Jennifer LewCFOSell1,786$2.98$5,322.28 2/13/2025Michael OverdorfEVPSell1,425$2.99$4,260.75 12/2/2024William H CarsonDirectorBuy3,200$5.33$17,056.00 10/15/2024Ted YednockEVPSell5,408$7.41$40,073.28 9/19/2024Ted YednockEVPSell4,500$7.10$31,950.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/5/2024Ted YednockEVPSell5,500$5.64$31,020.00 9/3/2024William H CarsonDirectorBuy3,200$5.48$17,536.00 8/29/2024Ted YednockEVPSell5,500$5.95$32,725.00 8/1/2024William H CarsonDirectorBuy3,200$6.24$19,968.00 7/15/2024Jennifer LewCFOSell1,104$6.03$6,657.12 7/15/2024Michael OverdorfEVPSell784$6.02$4,719.68 (Data available from 1/1/2013 forward) ANNX Insider Trading Activity - Frequently Asked Questions Who is on Annexon's Insider Roster? The list of insiders at Annexon includes Bain Capital Life Sciences Inv, Dean Richard Artis, Douglas Love, Jamie Dananberg, Jennifer Lew, Michael Overdorf, Muneer A Satter, Ted Yednock, and William H Carson. Learn more on insiders at ANNX. What percentage of Annexon stock is owned by insiders? 12.67% of Annexon stock is owned by insiders. Learn more on ANNX's insider holdings. Which Annexon insiders have been buying company stock? The following insiders have purchased ANNX shares in the last 24 months: Muneer A Satter ($1,008,000.00), and William H Carson ($100,106.90). How much insider buying is happening at Annexon? Insiders have purchased a total of 370,115 ANNX shares in the last 24 months for a total of $1,108,106.90 bought. Which Annexon insiders have been selling company stock? The following insiders have sold ANNX shares in the last 24 months: Dean Richard Artis ($16,379.55), Douglas Love ($46,844.23), Jamie Dananberg ($16,342.16), Jennifer Lew ($42,184.30), Michael Overdorf ($16,440.40), and Ted Yednock ($230,688.28). How much insider selling is happening at Annexon? Insiders have sold a total of 78,916 Annexon shares in the last 24 months for a total of $368,878.92 sold. Annexon Key ExecutivesMr. Douglas Love Esq. (Age 56)J.D., CEO, President & Director Compensation: $980.12k1 recent tradesDr. Dean R. Artis Ph.D. (Age 63)Chief Scientific Officer & Executive VP Compensation: $797.38kDr. Ted Yednock Ph.D. (Age 66)Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board Compensation: $697.76kMs. Jennifer Lew (Age 51)Executive VP, CFO & Corporate Secretary Compensation: $624.2k2 recent tradesMr. Michael Overdorf M.B.A. (Age 53)Executive VP & Chief Business Officer Compensation: $580.47k1 recent tradesHenk-Andre Kroon M.D.Senior Vice President of Translational MedicineDr. Jamie Dananberg M.D. (Age 66)Executive VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies HROW Insider Buying WVE Insider Buying AMPH Insider Buying GPCR Insider Buying COGT Insider Buying NTLA Insider Buying ARDX Insider Buying AUPH Insider Buying VERV Insider Buying COLL Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:ANNX) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.